These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 700890)

  • 21. Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor.
    Zajchowski DA; Sager R; Webster L
    Cancer Res; 1993 Oct; 53(20):5004-11. PubMed ID: 8402691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased sensitivity to interferon associated with in vitro transformation of X-ray-transformed C3H/10T1/2 cells.
    Brouty-Boyé D; Gresser I; Baldwin C
    Int J Cancer; 1979 Aug; 24(2):261-5. PubMed ID: 489167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different susceptibilities of human melanoma and breast carcinoma cell lines to retinoic acid-induced growth inhibition.
    Lotan R
    Cancer Res; 1979 Mar; 39(3):1014-9. PubMed ID: 427741
    [No Abstract]   [Full Text] [Related]  

  • 24. Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents.
    Rubin BY; Gupta SL
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):5928-32. PubMed ID: 6160587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon and spontaneous cytotoxicity in man. I. Enhancement of the spontaneous cytotoxicity of peripheral lymphocytes by human leukocyte interferon.
    Einhorn S; Blomgren H; Strander H
    Int J Cancer; 1978 Oct; 22(4):405-12. PubMed ID: 700895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiproliferative effects of interferons on human melanoma cells in the human tumor colony-forming assay.
    Schiller JH; Willson JK; Bittner G; Wolberg WH; Hawkins MJ; Borden EC
    J Interferon Res; 1986 Dec; 6(6):615-25. PubMed ID: 2437222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of cell proliferation by interferons. Relative contributions of changes in protein synthesis and breakdown to growth control of human lymphoblastoid cells.
    McNurlan MA; Clemens MJ
    Biochem J; 1986 Aug; 237(3):871-6. PubMed ID: 2432876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Additive and synergistic effects of a novel antiestrogen, toremifene (Fc-1157a), and human interferons on estrogen responsive MCF-7 cells in vitro.
    Kangas L; Nieminen AL; Cantell K
    Med Biol; 1985; 63(4):187-90. PubMed ID: 2419713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterisation and properties of a small cell lung cancer cell line and xenograft WX322 with marked sensitivity to alpha-interferon.
    Langdon SP; Rabiasz GJ; Anderson L; Ritchie AA; Fergusson RJ; Hay FG; Miller EP; Mullen P; Plumb J; Miller WR
    Br J Cancer; 1991 Jun; 63(6):909-15. PubMed ID: 1712622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proliferation kinetics of a human breast cancer line in vitro following treatment with 17beta-estradiol and 1-beta-D-arabinofuranosylcytosine.
    Weichselbaum RR; Hellman S; Piro AJ; Nove JJ; Little JB
    Cancer Res; 1978 Aug; 38(8):2339-42. PubMed ID: 667830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression.
    Shekhar MP; Werdell J; Santner SJ; Pauley RJ; Tait L
    Cancer Res; 2001 Feb; 61(4):1320-6. PubMed ID: 11245428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assay of growth inhibition in lymphoblastoid cell cultures.
    Evinger M; Pestka S
    Methods Enzymol; 1981; 79(Pt B):362-8. PubMed ID: 6173685
    [No Abstract]   [Full Text] [Related]  

  • 33. Interferon therapy for neoplastic diseases in man in vitro and in vivo studies.
    Einhorn S; Strander H
    Adv Exp Med Biol; 1978; 110():159-74. PubMed ID: 727040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon and cell division. I. Inhibition of the multiplication of mouse leukemia L 1210 cells in vitro by interferon preparations.
    Gresser I; Brouty-Boyé D; Thomas MT; Macieira-Coelho A
    Proc Natl Acad Sci U S A; 1970 Aug; 66(4):1052-8. PubMed ID: 4319881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon and spontaneous cytotoxicity in man. IV. Evidence for interferon as the factor in human interferon preparations causing enhancement of spontaneous cytotoxicity.
    Einhorn S
    J Clin Lab Immunol; 1980 Jan; 3(1):35-8. PubMed ID: 6155470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The in vitro interaction of RA-233 and several interferons on human cell lines.
    Wolf LM; Leitzel KE; Harvey HA; Lipton A
    J Med; 1984; 15(1):15-21. PubMed ID: 6436421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human fibroblast interferon in human neoplasia: clinical and laboratory study.
    Horoszewicz JS; Leong SS; Ito M; Buffett RF; Karakousis C; Holyoke E; Job L; Dölen JG; Carter WA
    Cancer Treat Rep; 1978 Nov; 62(11):1899-906. PubMed ID: 728909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Noncycling tumor cells are sensitive targets for the antiproliferative activity of human interferon.
    Horoszewicz JS; Leong SS; Carter WA
    Science; 1979 Nov; 206(4422):1091-3. PubMed ID: 493995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells.
    Sutherland RL; Hall RE; Pang GY; Musgrove EA; Clarke CL
    Cancer Res; 1988 Sep; 48(18):5084-91. PubMed ID: 2970295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon enhancement of the invasive capacity of Ewing sarcoma cells in vitro.
    Siegal GP; Thorgeirsson UP; Russo RG; Wallace DM; Liotta LA; Berger SL
    Proc Natl Acad Sci U S A; 1982 Jul; 79(13):4064-8. PubMed ID: 6180434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.